Stock APGE APOGEE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Apogee Therapeutics, Inc.

Equities

APGE

US03770N1019

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-21 EDT 		5-day change 1st Jan Change
38 USD -0.13% Intraday chart for Apogee Therapeutics, Inc. -7.63% +36.01%
05-28 Apogee Therapeutics, Inc. Appoints Lisa Bollinger to Its Board of Directors CI
05-15 Apogee Announces Dosing of First Patient in Phase 2 Atopic Dermatitis Trial of APG777, a Novel Subcutaneous Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases CI
9f6.wkd4psO6jnmo2JtvR4f2HFugrmJgwZf93PnNsbHhVTk.lQ0L1bHd-iP6m9cIMdi8di3H-SlZpq-biJKjx9_VI0-dMwvg8fy7DfqK9A~ec2f770e70d6d8032d987bd74c71cc0d
  1. Stock Market
  2. Equities
  3. APGE Stock
  4. Charts Apogee Therapeutics, Inc.
  5. News Chart